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Abstract-The distribution of estrogen receptor between the cytO$olic and IIIlclear co~partmeatswereevKtuatediit 
liver of male rats to determine whether a circadian rhythm exists. Cytosolk receptor reached a maximuliller~lKt·· . 
400 hours and a minimum at 2000 and 2400 hr. Nuclear receptor reached .amadmumlevel at 801) tir and lffDlfpDkl~Ai 
at 1600 and 2000 hr. Serum estradiol levels were also highest at 800 hr and lowest at 1600&r. qltevariKtilnsg~ .. 
cytosolic and nuclear receptors are not reciprocal; in fact, the overall content of receptor in the liver jsnot~K· . 
and aL'lo displays a circadian rhythm. ... . .. ' 
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removed quickly and placed immediately in ice 
cold TEM (0.01 M Tris-HCl, 1.5 mM EDTA, 
20 mM sodium molybdate,. pH 7.4) buffer. 
Livers were homogenized im~ediately after all 
animals were killed. 
Materials. Radioactive [2, 4, 6, 7 3H]-estradiol, 
97 Cilmmol (eH]-E 2), was obtained from New 
England Nuclear, Boston, MA. Purity of radio-
labeled compounds was assessed periodically by 
thin layer chromatography (2). Sources of other 
substances were previously described (2, 10, 12). 
Buffers used in preparation of nuclei and cytosol 
contained leupeptin (0.15 mM) and benzamidine 
( 1.0 mM), protease inhibitors which stabilize the 
activity of the estrogen receptor. 
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The precipitates were washed as described (12) 
and the radioactivity content determined. The 
nuclear receptor content was determined by an 
exchange assay described previously (12), which 
involves incubat~on of aliquots (200p.l) of the 
nuclear suspension with 10 nM of [>H}Ez in the 
presence and absence of a 2S0-fold excess of 
unlabeled DES for 60 min at 30°C. The unbound 
steroid was removed by washing the nuclear 
pellet 5 times with SMgHM buffer. The washed 
pellet was then extracted with 2 ml of ethanol for 
2 hr at 30°C and the entire extract and pellet were 
transferred to a 20 ml scintillation vial, and 8 ml 
of ACS scintillation fluid (Amersham) were 
added. Additional details of subcellular fraction-
ation and assay conditions may be found in 
Reference (12). 
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groups (P < 0.001). After this time, the level of 
cER falls until at 2400 hr, \t is almost un-
detectable. In fact, in two animals at 2000 hr and 
three animals at 2400 hr, no specific binding of 
[3H]-Ez was detectable. The affinity of the cER 
for E2 did not vary as a function of these changes 
in receptor levels; the Kd values for cER at all 
time points were similar (range, 0.8-1.5 nM). 
The level of the nuclear receptor reached a 
maximal value at 800 hr (5.0 ± 1.4 pmol/mg 
DNA), although this value was not significantly 
different from that observed at 400 hr and 
2400 hr. It was, however, significantly different 
than the values at either 1200 hr (P < 0.005), or 
209 
at 1600 hr or 2000 hr (P <: 0.001). The lowest 
value for the nuclear ER was observed at 1600 hr 
(0.2 ± 0.2 pmol/rug DNA)- The level of nucl~ar 
ER varied in the same fashion as serum estradlOl 
levels (Figure 1) i~ that the latter was relatively 
high at 800 hr (12 pg/mi) as .compared to that.at 
1600 hr (4 pg/mJ). 
Hepatic content of both forms of the receptor 
is illustrated in Figure 2. At all time points the 
nuclear form of the rec·eptO! predominates. 
Recent studies (17-19) have indicated that 
steroid receptors may in fact reside only in the 
nucleus of the cell, and that cytosolic receptors 
represent artifacts of cell breakage. However, the 
210 
12 
~ 9 
E 
CJ. 
u 
c 
i5 6 
Ll 
-' 
o 
"0 
o 
... 
~ 3 
Chronobio!ogy International 
w 
,l, I 
~ I 
w 
0.00 4.00 8.00 12.00 16.00 20.00 24.00 
CLOck time (hrj 
Figure 2. Variations in total hepatic content of estrogen 
receptor at different times of day. The height of each bar 
represents the total receptor content (cytosolic and nuclear) 
corrected for and expressed as binding per gram of liver. The 
shaded area of each bar represents the contribution of the 
nuclear receptor to the total amount. 
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